共 50 条
- [41] Targeting Glutathione Reductase in KEAP1/NRF2 Mutant NSCLCFREE RADICAL BIOLOGY AND MEDICINE, 2022, 192Jiang, ChangDeNicola, Gina
- [42] TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignanciesCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (02) : 261 - 273Burris, Howard A., IIIKurkjian, C. D.Hart, L.Pant, S.Murphy, P. B.Jones, S. F.Neuwirth, R.Patel, C. G.Zohren, F.Infante, J. R.
- [43] Comprehensive multi-omics analysis unveils NFE2L2/KEAP1 mutations as key drivers of treatment resistance in esophageal squamous cell carcinoma during chemoradiotherapyCANCER RESEARCH, 2024, 84 (07)Zhao, KuaileChen, HuXun, ZhenzhenDeng, JiayingLuo, YikaiYe, JinjunChen, JunqiangChen, WeiweiLi, JunLiang, Han
- [44] Genomic alterations of KEAP1/NFE2L2/CUL3(K/N/C) in Chinese lung cancer patients (pts)ANNALS OF ONCOLOGY, 2020, 31 : S1118 - S1118Qian, C.Wang, C.Wang, X.He, Q.Ma, T.Zhang, X.
- [45] PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative RadiotherapyJOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 630 - 634Bourbonne, VincentMorjani, MoncefPradier, OlivierHatt, MathieuJaouen, VincentQuerellou, SoleneVisvikis, DimitrisLucia, FrancoisSchick, Ulrike
- [46] TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignanciesCancer Chemotherapy and Pharmacology, 2017, 80 : 261 - 273Howard A. BurrisC. D. KurkjianL. HartS. PantP. B. MurphyS. F. JonesR. NeuwirthC. G. PatelF. ZohrenJ. R. Infante
- [47] KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical TrialsFRONTIERS IN ONCOLOGY, 2021, 11Zhu, HongyuanXie, DaipengYu, YunfangYao, LintongXu, BinHuang, LuyuWu, ShaoweiLi, FashengZheng, YatingLiu, XinyiXie, WenzhuanHuang, MengliLi, HaoZheng, ShaopengZhang, DongkunQiao, GuibinChan, Lawrence W. C.Zhou, Haiyu
- [48] An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2′-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanomaHISTOLOGY AND HISTOPATHOLOGY, 2017, 32 (02) : 129 - 136Hintsala, Hanna-RiikkaHaapasaari, Kirsi-MariaSoini, YlermiKarihtala, Peeter
- [49] Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorNature Medicine, 2010, 16 : 205 - 213Matthew R JanesJose J LimonLomon SoJing ChenRaymond J LimMelissa A ChavezCollin VuMichael B LillySharmila MallyaS Tiong OngMarina KonoplevaMichael B MartinPingda RenYi LiuChristian RommelDavid A Fruman
- [50] Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorNATURE MEDICINE, 2010, 16 (02) : 205 - U115Janes, Matthew R.Limon, Jose J.So, LomonChen, JingLim, Raymond J.Chavez, Melissa A.Vu, CollinLilly, Michael B.Mallya, SharmilaOng, S. TiongKonopleva, MarinaMartin, Michael B.Ren, PingdaLiu, YiRommel, ChristianFruman, David A.